亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

武漢遠成藥業有限公司營銷七組  

精細化工,香精香料,食品添加劑,醫藥原料及中間體

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:羅蓉軍
  • 電話:027-88085965
  • 郵件:lrj@ycphar.com
  • 傳真:027-88048077
  • QQ:2355327175
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 環吡司胺
環吡司胺
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
品牌 南箭
過期 長期有效
更新 2019-06-04 10:00
 
詳細信息
 環吡司胺 
中文同義詞: 環匹羅司乙醇胺;6-環己基-1-羥基-4-甲基吡啶-2(1H)-酮 2-氨基乙醇;環吡司胺;環吡酮胺;6-環己基-1-羥基-4-甲基吡啶-2(1H)-酮;環吡酮(巴特芬);環吡酮胺雜質;二甲他林原料藥 
英文名稱: Ciclopirox ethanolamine 
英文同義詞: 6-CYCLOHEXYL-1-HYDROXY-4-METHYL-1H-PYRIDIN-2-ONE, 2-AMINO-ETHANOL;6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2[1H]-PYRIDONE ETHANOLAMINE SALT;6-CYCLOHEXYL-1-HYDROXY-4-METHYL-2(1H)-PYRIDONE ETHANOLAMMonIUM SALT;6-cyclohexyl-1-hydroxy-4-methylpyridin-2(1h)-one 2-aminoethanol (1:1);ciclopirox ethanolamine;CICLOPIROXOLAMINE;2-aminoethanol*pd.with6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridinone(;6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridinon*pd.with2-aminoethanol 
CAS號: 41621-49-2 
分子式: C14H24N2O3 
分子量: 268.35 
EINECS號: 255-464-9 
標準: USP 
有無證: 無證 
天然/合成: 合成 
級別: 通用級 
含量: 99% 
外觀: 白色粉狀 
包裝: 25kg/紙板桶 可拆分 
成份:  
理化屬性:  
類別: 醫藥原料 
行業: 醫藥原料 
領域: 抑菌殺菌劑 
下延產品: 環吡酮胺軟膏 
運用: 臨床上主要用于淺部皮膚真菌感染,如體癬、腳癬、股癬,手、足癬(尤其是角化增厚型),花斑癬,皮膚念珠菌病,白色念珠菌及甲癬的治療。 
 
 
2950/KG
©2025 武漢遠成藥業有限公司營銷七組 版權所有   技術支持:化工網   訪問量:17666  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |